Manolagas S C, Taylor C M, Anderson D C
J Endocrinol. 1979 Jan;80(1):35-9. doi: 10.1677/joe.0.0800035.
A method developed initially for the detection of high-affinity binding of glucocorticoids in the cytosol from foetal rat calvaria has been adapted for metabolites of vitamin D. Consistent displacement of [3H]1,25-dihydroxycholecalciferol ([3H]1,25(OH)2D3) by unlabelled 1,25(OH)2D3 was obtained with an apparent dissociation constant (Kd) of 2.3 x 10(-9) mol/l. The specificity of this binding was examined by competition experiments. Displacement of labelled 1,25(OH)2D3 by a 100-fold excess of unlabelled metabolites, expressing the fall with unlabelled 1,25(OH)2D3 as 100%, was as follows: 25-hydroxycholecalciferol (25(OH)D3), 61%; 24,25-dihydroxycholecalciferol, 29%; cholecalciferol, 3%. These are similar to results for the chick mucosa nuclear 1,25(OH)2D3 receptor. No displacement was obtained with corticosterone, testosterone, oestradiol or progesterone. When [3H]25(OH)D3 was used as ligand, a displacement curve with unlabelled 25(OH)D3 indicated only binding with a greater Kd (approximately 10(-7) mol/l). These data suggest a direct action of 1,25(OH)2D3 on bone which is similar to that of steroid hormones on their target tissues.
最初开发用于检测胎鼠颅骨细胞质中糖皮质激素高亲和力结合的一种方法已被改编用于维生素D的代谢产物。未标记的1,25-二羟胆钙化醇([3H]1,25(OH)2D3)能一致地取代[3H]1,25-二羟胆钙化醇,其表观解离常数(Kd)为2.3×10^(-9) mol/l。通过竞争实验检测了这种结合的特异性。用100倍过量的未标记代谢产物取代标记的1,25(OH)2D3,以未标记的1,25(OH)2D3的取代率为100%,结果如下:25-羟胆钙化醇(25(OH)D3),61%;24,25-二羟胆钙化醇,29%;胆钙化醇,3%。这些结果与鸡黏膜细胞核1,25(OH)2D3受体的结果相似。皮质酮、睾酮、雌二醇或孕酮未产生取代作用。当使用[3H]25(OH)D3作为配体时,未标记的25(OH)D3的取代曲线表明只有结合,且Kd更大(约10^(-7) mol/l)。这些数据表明1,25(OH)2D3对骨骼有直接作用,这与甾体激素对其靶组织的作用相似。